• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Amphetamines and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenethylamines Amphetamines and derivatives

Compound Introduction: (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-amino-1,6-diphenylhexane (CAS No. 192725-49-8)

The compound (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-amino-1,6-diphenylhexane, identified by its CAS number 192725-49-8, represents a significant advancement in the field of chiral chemistry and pharmaceutical research. This molecule, characterized by its complex stereochemistry and functional groups, has garnered attention for its potential applications in drug development and molecular recognition.

At the core of this compound's structure lies its stereochemical configuration, specifically the (2S,3S,5S) arrangement of its chiral centers. This precise three-dimensional arrangement is crucial for its biological activity and interaction with target molecules. The presence of multiple stereocenters makes this compound a valuable scaffold for studying enantioselective processes in biochemical systems.

The pharmacophoric features of (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-amino-1,6-diphenylhexane include the hydroxyl and amino groups, which contribute to its solubility and reactivity. Additionally, the 2-(2,6-Dimethylphenoxyacetyl) moiety introduces a phenolic component that can participate in hydrogen bonding interactions, enhancing its binding affinity to biological targets. These structural elements make it a promising candidate for further exploration in medicinal chemistry.

In recent years, there has been a growing interest in the development of chiral drugs due to their improved efficacy and reduced side effects compared to their racemic counterparts. The compound CAS No. 192725-49-8 exemplifies this trend by incorporating advanced stereochemical design principles. Its synthesis requires precise control over reaction conditions to ensure the correct stereochemical outcome, highlighting the importance of high-quality synthetic methodologies in modern drug discovery.

Recent studies have demonstrated the potential of this compound as a building block for more complex molecules. Researchers have leveraged its structural features to develop novel derivatives with enhanced pharmacological properties. For instance, modifications to the phenolic group have been shown to modulate receptor binding affinity and metabolic stability. These findings underscore the versatility of (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-amino-1,6-diphenylhexane in addressing diverse therapeutic challenges.

The< strong>1,6-diphenylhexane backbone provides a rigid framework that can be exploited for optimizing drug-like properties such as lipophilicity and solubility. This structural motif has been extensively studied in the context of CNS drug delivery due to its ability to cross the blood-brain barrier efficiently. By incorporating functional groups like hydroxyl and amino moieties at specific positions along this backbone, researchers can fine-tune the pharmacokinetic profile of their lead compounds.

The< strong>hydroxyl and< strong>amino groups present in this compound are particularly noteworthy for their role in mediating interactions with biological targets. Hydroxyl groups are known to participate in hydrogen bonding networks, which are critical for enzyme-substrate binding and receptor-ligand interactions. Similarly,< strong.amino groups can engage in ionic or polar interactions depending on the local environment within a biological system.

The< strong>Dimethylphenol moiety at position 2 introduces additional complexity to the molecule's behavior. This aromatic group can influence electronic properties through conjugation with adjacent functional units and may contribute to hydrophobic interactions with lipid environments. Such features are often exploited in designing molecules that require specific solubility profiles or target tissue penetration capabilities.

In conclusion,< strong>(2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-amino-1,6-diphenylhexane, with its CAS number< strong>CAS No. 192725-49-8, represents a sophisticated example of how stereochemical design can be leveraged to develop novel pharmaceutical candidates. Its multifaceted structural features offer opportunities for further exploration across various therapeutic areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)